These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Definition of a new cut-off for the anti-phospholipase A2 receptor (PLA2R) autoantibody immunoassay in patients affected by idiopathic membranous nephropathy. Tampoia M; Migliucci F; Villani C; Abbracciavento L; Rossini M; Fumarulo R; Gesualdo L; Montinaro V J Nephrol; 2018 Dec; 31(6):899-905. PubMed ID: 30187382 [TBL] [Abstract][Full Text] [Related]
3. PLA2R and membranous nephropathy: A 3 year prospective Australian study. Hill PA; McRae JL; Dwyer KM Nephrology (Carlton); 2016 May; 21(5):397-403. PubMed ID: 26369693 [TBL] [Abstract][Full Text] [Related]
4. Anti-PLA2R Antibodies in Chinese Patients with Membranous Nephropathy. Li X; Wei D; Zhou Z; Wang B; Xu Y; Pan J; Yang C; Lu J; Qiu Y Med Sci Monit; 2016 May; 22():1630-6. PubMed ID: 27179439 [TBL] [Abstract][Full Text] [Related]
5. Antiphospholipase A2 Receptor Antibody Levels Predict the Risk of Posttransplantation Recurrence of Membranous Nephropathy. Quintana LF; Blasco M; Seras M; Pérez NS; López-Hoyos M; Villarroel P; Rodrigo E; Viñas O; Ercilla G; Diekmann F; Gómez-Roman JJ; Fernandez-Fresnedo G; Oppenheimer F; Arias M; Campistol JM Transplantation; 2015 Aug; 99(8):1709-14. PubMed ID: 25675198 [TBL] [Abstract][Full Text] [Related]
6. Enhanced expression of the M-type phospholipase A2 receptor in glomeruli correlates with serum receptor antibodies in primary membranous nephropathy. Hoxha E; Kneißler U; Stege G; Zahner G; Thiele I; Panzer U; Harendza S; Helmchen UM; Stahl RA Kidney Int; 2012 Oct; 82(7):797-804. PubMed ID: 22673885 [TBL] [Abstract][Full Text] [Related]
7. Diagnostic specificity of autoantibodies to M-type phospholipase A2 receptor (PLA2R) in differentiating idiopathic membranous nephropathy (IMN) from secondary forms and other glomerular diseases. Radice A; Pieruzzi F; Trezzi B; Ghiggeri G; Napodano P; D'Amico M; Stellato T; Brugnano R; Ravera F; Rolla D; Pesce G; Giovenzana ME; Londrino F; Cantaluppi V; Pregnolato F; Volpi A; Rombolà G; Moroni G; Ortisi G; Sinico RA J Nephrol; 2018 Apr; 31(2):271-278. PubMed ID: 29081027 [TBL] [Abstract][Full Text] [Related]
8. Prevalence, diagnostic value and clinical characteristics associated with the presence of circulating levels and renal deposits of antibodies against the M-type phospholipase A2 receptor in idiopathic membranous nephropathy. Segarra-Medrano A; Jatem-Escalante E; Quiles-Pérez MT; Salcedo MT; Arbós-Via MA; Ostos H; Valtierra N; Carnicer-Cáceres C; Agraz-Pamplona I Nefrologia; 2014 May; 34(3):353-9. PubMed ID: 24798555 [TBL] [Abstract][Full Text] [Related]
9. Clinical usefulness of autoantibodies to M-type phospholipase A2 receptor (PLA2R) for monitoring disease activity in idiopathic membranous nephropathy (IMN). Radice A; Trezzi B; Maggiore U; Pregnolato F; Stellato T; Napodano P; Rolla D; Pesce G; D'Amico M; Santoro D; Londrino F; Ravera F; Ortisi G; Sinico RA Autoimmun Rev; 2016 Feb; 15(2):146-54. PubMed ID: 26527329 [TBL] [Abstract][Full Text] [Related]
10. Detection of PLA2R Autoantibodies before the Diagnosis of Membranous Nephropathy. Burbelo PD; Joshi M; Chaturvedi A; Little DJ; Thurlow JS; Waldman M; Olson SW J Am Soc Nephrol; 2020 Jan; 31(1):208-217. PubMed ID: 31843984 [TBL] [Abstract][Full Text] [Related]
11. Circulating antibodies to α-enolase and phospholipase A Kimura Y; Miura N; Debiec H; Morita H; Yamada H; Banno S; Ronco P; Imai H Clin Exp Nephrol; 2017 Feb; 21(1):117-126. PubMed ID: 26830547 [TBL] [Abstract][Full Text] [Related]
12. Anti-phospholipase A2 receptor antibody in membranous nephropathy. Qin W; Beck LH; Zeng C; Chen Z; Li S; Zuo K; Salant DJ; Liu Z J Am Soc Nephrol; 2011 Jun; 22(6):1137-43. PubMed ID: 21566055 [TBL] [Abstract][Full Text] [Related]
13. Autoantibodies against phospholipase A2 receptor in Korean patients with membranous nephropathy. Oh YJ; Yang SH; Kim DK; Kang SW; Kim YS PLoS One; 2013; 8(4):e62151. PubMed ID: 23637987 [TBL] [Abstract][Full Text] [Related]
14. Clinical usefulness of anti-M-type phospholipase-A-receptor antibodies in patients with membranous nephropathy and the comparison of three quantification methods. Katsumata Y; Okamoto Y; Moriyama T; Moriyama R; Kawamoto M; Hanaoka M; Uchida K; Nitta K; Harigai M Immunol Med; 2020 Mar; 43(1):47-56. PubMed ID: 31910103 [TBL] [Abstract][Full Text] [Related]
16. Expression of phospholipase A2 receptor and IgG4 in patients with membranous nephropathy. Liu L; Chang B; Wu X; Guo Y; Pan Y; Yang L Vasc Health Risk Manag; 2018; 14():103-108. PubMed ID: 29881283 [TBL] [Abstract][Full Text] [Related]
18. Circulating anti-phospholipase A2 receptor antibodies as a diagnostic and prognostic marker in Greek patients with idiopathic membranous nephropathy - a retrospective cohort study. Provatopoulou S; Kalavrizioti D; Stangou M; Kouri MN; Kalliakmani P; Papasotiriou M; Papachristou E; Goumenos DS; Papagianni A Rom J Intern Med; 2019 Jun; 57(2):141-150. PubMed ID: 30864406 [TBL] [Abstract][Full Text] [Related]
19. The Sensitivity and Specificity of Serum Phospholipase A2 Receptor Antibodies in Diagnosing Primary Membranous Nephropathy in Patients with Adult Nephrotic Syndrome and its Correlation with Serum Phospholipase A2 Receptor Staining in Kidney Biopsies. Vellakampadi D; Bonu R; Siddini V; Vankalakunti M Saudi J Kidney Dis Transpl; 2023 Sep; 34(5):416-426. PubMed ID: 38995300 [TBL] [Abstract][Full Text] [Related]
20. Antiphospholipase A₂ receptor autoantibodies: a comparison of three different immunoassays for the diagnosis of idiopathic membranous nephropathy. Behnert A; Schiffer M; Müller-Deile J; Beck LH; Mahler M; Fritzler MJ J Immunol Res; 2014; 2014():143274. PubMed ID: 24812637 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]